OKG, Arginine, and Citrulline: Why How You Take Them Matters as Much as What You Take
Three compounds that all feed the same healing pathway — but with completely different bioavailability, food interactions, and clinical evidence behind them.
with OKG (Meaume 2009)
to First-Pass Metabolism
from Citrulline vs Arginine
OKG Recovery RCT
If you've ever taken arginine and wondered why you didn't feel much — or read conflicting advice about whether to take it with food — there's a well-documented biochemical explanation. The same healing pathway is accessed by OKG, arginine, and citrulline, but each compound gets there differently, and those differences directly affect how well they work.
The Healing Bottleneck Most Supplements Miss
Wound healing, post-surgical recovery, and injury repair all share a common metabolic need: your body requires L-arginine in sufficient quantity to produce nitric oxide (NO) and a cascade of structural molecules — polyamines that drive cell proliferation, and proline that builds collagen. Without enough arginine at the site of repair, each phase of healing — inflammation, new tissue formation, and remodelling — is compromised.
The problem is that during injury, surgery, or prolonged illness, arginine demand spikes dramatically while dietary intake often falls. Your body can't manufacture enough from scratch to keep up. This is why arginine is classified as "conditionally essential" — in healthy people it's not a problem, but during healing it becomes a genuine bottleneck.
Three nutritional compounds can help fill this gap: ornithine alpha-ketoglutarate (OKG), L-arginine itself, and L-citrulline. They all feed the same pathway, but from very different metabolic starting points — and understanding those differences changes how and when you should take them.
Three Compounds, One Pathway — But Very Different Routes
Think of the arginine-nitric oxide pathway as a river. You can add water upstream, midstream, or directly at the point where the current is running. OKG is upstream — it generates arginine along with other healing molecules. Direct arginine is dropping water straight in the middle of the river, but a lot evaporates before it gets anywhere useful. Citrulline is the longest route — further upstream — but surprisingly, it gets more water to the end than arginine does.
How the Three Compounds Work: Four Key Mechanisms
OKG: The Metabolite Generator
OKG is a salt of ornithine and alpha-ketoglutarate (2:1 ratio). When taken together, they saturate ornithine aminotransferase (OAT), flooding the system with arginine, proline, glutamine, and polyamines simultaneously — the complete toolkit for tissue repair. Animal studies confirm the combined salt works better than either compound given separately.
Arginine: The Direct Substrate (With a Catch)
L-arginine is the direct raw material for nitric oxide synthase (NOS) in wound-site cells. But it faces the "arginine paradox" — even when there appears to be enough arginine inside cells, exogenous arginine continues to drive NO production. This is because NOS is physically co-localised with the arginine transporter (CAT-1) in a membrane compartment that depends on continuous outside supply.
Citrulline: The Bypass Artist
Citrulline avoids all the traps that limit arginine. It's absorbed via neutral amino acid transporters (not the competitive CAT-1 pathway), passes through the liver without being broken down, and is converted to arginine in the kidney via the ASS/ASL enzyme pair. The result: more of what you take actually reaches the bloodstream as arginine.
Alpha-Ketoglutarate (AKG): The Collagen Cofactor
The AKG component of OKG has its own distinct role — it's a cofactor for prolyl hydroxylase, the enzyme that cross-links collagen into strong, stable fibres. This is why OKG contributes to structural tissue repair at a level that neither arginine nor citrulline alone can match.
What the Clinical Research Shows
OKG has the most direct wound healing evidence of the three, supported by two well-designed multicentre randomised controlled trials. Arginine is mechanistically essential and has extensive supporting biology, but direct arginine wound healing RCTs are largely embedded in multi-nutrient formulas where attribution is unclear. Citrulline is the pharmacokinetically superior arginine precursor but lacks its own wound healing trials.
Meaume et al. (2009) randomised 160 elderly patients with Stage II/III heel pressure ulcers to oral OKG 10 g/day or placebo for 6 weeks in a multicentre, double-blind, placebo-controlled design. The OKG group showed a mean wound area reduction of −0.07 cm²/day vs. −0.04 cm²/day in controls — a 43% improvement (p=0.007). No treatment-related serious adverse events occurred. This remains the strongest direct evidence for any single arginine-pathway supplement in wound healing.
The Food Timing Question: Why It's Different for Each Compound
Here's where the practical guidance gets specific — and where the science often gets misrepresented. Each compound has a different relationship with food, and those differences are pharmacologically grounded.
Arginine needs to be taken on an empty stomach. Arginine is absorbed via the CAT-1 transporter (SLC7A1), which is saturable and shared by all cationic amino acids — including lysine and ornithine, which are abundant in protein-rich food. When you eat a meal alongside arginine, competing amino acids flood the same transporter and reduce arginine absorption efficiency. Mariotti et al. (2013) confirmed that about 60% of dietary arginine is already destroyed in first-pass splanchnic metabolism even under normal conditions. Adding food on top means the fraction that gets through drops further. The NOS enzyme is also physically co-localised with this transporter in cell membranes, meaning transport efficiency directly determines NO production — not just circulating arginine levels.
Citrulline doesn't compete at the CAT-1 transporter. It's absorbed via neutral amino acid transporters, bypasses the liver (which normally breaks down arginine via arginase), and gets converted to arginine in the kidney at a steady, sustained rate. You can take it with or without food, and it will still raise plasma arginine more effectively than arginine taken on an empty stomach. For sustained support across a day of healing, citrulline is the more reliable option — and co-administration with arginine makes pharmacokinetic sense: the arginine gives you an immediate peak, the citrulline gives you the sustained baseline.
OKG is food-independent. OKG's healing effects work through saturating the OAT enzyme system — a mechanism that doesn't depend on CAT-1 competition. The AKG moiety enters cells via entirely different transporters. All of the published OKG clinical trials dosed patients without a fasted-state requirement, and the results were consistent. This makes OKG the most practically flexible of the three, particularly for patients who are eating regularly as part of their recovery.
The Evidence-Based Protocol
| Compound | Studied Dose | Timing | Food Interaction |
|---|---|---|---|
| OKG | 10 g/day (oral, pressure ulcers); 20–30 g/day (enteral, burns) | Any time | None — food-independent |
| L-Citrulline | 3–6 g/day | Any time; may combine with arginine | Minimal — neutral transporter absorption |
| L-Arginine | 3–10 g/day | On an empty stomach (30–60 min before meals) | Significant — CAT-1 competition with food protein |
| Combine with | Adequate dietary protein (1.2–1.6 g/kg/day), Vitamin C (collagen synthesis cofactor), physiotherapy and structured rehabilitation | ||
| Safety | OKG well tolerated at 10–30 g/day across 30+ years of clinical data. Citrulline and arginine tolerated at standard doses; high-dose arginine may cause GI discomfort | ||
What the Research Doesn’t Yet Tell Us
The most important gap in this area is the absence of a combined-use clinical trial. The complementarity of OKG + citrulline + arginine is mechanistically compelling, but no RCT has tested the combination against any individual compound or against standard care. The three-compound protocol described above is pharmacologically logical — not empirically confirmed. It is also theoretically possible that high-dose ornithine (from OKG) could compete with arginine at the CAT-1 transporter in a combined protocol, which would undermine the synergy. This interaction has not been characterised in humans.
The pharmacokinetic superiority of citrulline over arginine has also been demonstrated primarily in healthy volunteers and mouse models, not specifically in wound healing patients. Whether the same advantage holds in elderly, post-surgical, or severely burned patients — who have different transporter expression and metabolic states — is an open research question. And OKG's landmark trials, while rigorous for their time, are now 15–30 years old and have not been independently replicated with modern trial designs.
Explore the Full Research
- 📄 Clinical Evidence One-Pager (PDF) — concise summary for clinicians and coaches
- 📋 Full Research Paper (PDF) — complete literature synthesis with evidence tables
- 🔗 Full Reference List — all cited sources in Vancouver format
Ready to Dig Into the Full Evidence?
Download the complete clinical research paper on OKG, arginine, and citrulline — including evidence tables, dosing comparisons, and references to every study cited here.
Download the Full Research PaperKey References
- Meaume S, et al. Efficacy and safety of ornithine alpha-ketoglutarate in heel pressure ulcers in elderly patients. J Nutr Health Aging. 2009;13(7):623-630.
- Brocker P, et al. A two-centre, randomized, double-blind trial of ornithine oxoglutarate in 194 elderly, ambulatory, convalescent subjects. Age Ageing. 1994;23(4):303-306.
- Agarwal U, et al. Supplemental Citrulline Is More Efficient Than Arginine in Increasing Systemic Arginine Availability in Mice. J Nutr. 2017;147(4):594-600.
- Schwedhelm E, et al. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol. 2008;65(1):51-59.
- Mariotti F, et al. Kinetics of the utilization of dietary arginine for nitric oxide and urea synthesis. Am J Clin Nutr. 2013;97(5):972-979.
- Cynober L. Ornithine alpha-ketoglutarate as a potent precursor of arginine and nitric oxide. J Nutr. 2004;134(10 Suppl):2858S-2862S.
- Witte MB, Barbul A. Arginine physiology and its implication for wound healing. Wound Repair Regen. 2003;11(6):419-423.